Literature DB >> 14515146

Regulatory mechanisms for the expression and activity of platelet-derived growth factor receptor.

Keiko Funa1, Hidetaka Uramoto.   

Abstract

PDGF is one of the most potent serum mitogens, and the signalling mechanism by way of its receptor tyrosine-kinase has been extensively studied since its first purification in 1979. The identification of homology between the simian sarcoma virus oncogene, v-sis, and the B-chain of PDGF, as well as the frequent over-expression of both the ligands and receptors in various tumours and stroma led to the proposal of the PDGF-mediated autocrine and paracrine hypothesis. Consistent with the important roles of PDGF in the growth and survival of cells, the expression and activity of PDGF receptors are tightly controlled by both positive and negative feedback mechanisms at different levels. The deregulation of the control system can result in serious pathological conditions such as chronic inflammation and tumours. Understanding the molecular mechanisms for the regulatory system and the signalling pathway of PDGF is essential in order to find effective therapies in the diseases where PDGF is involved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14515146     DOI: 035003647

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  13 in total

1.  Molecular cloning of the human platelet-derived growth factor receptor beta (PDGFR-beta) promoter and drug targeting of the G-quadruplex-forming region to repress PDGFR-beta expression.

Authors:  Yong Qin; Jessica S Fortin; Denise Tye; Mary Gleason-Guzman; Tracy A Brooks; Laurence H Hurley
Journal:  Biochemistry       Date:  2010-05-18       Impact factor: 3.162

Review 2.  The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis.

Authors:  Clair Crewe; Yu Aaron An; Philipp E Scherer
Journal:  J Clin Invest       Date:  2017-01-03       Impact factor: 14.808

3.  Inflammatory cytokine levels in patients with periodontitis and/or coronary heart disease.

Authors:  Haihua Zhu; Xiaolong Lin; Pei Zheng; Hui Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  Platelet-derived growth factor-DD targeting arrests pathological angiogenesis by modulating glycogen synthase kinase-3beta phosphorylation.

Authors:  Anil Kumar; Xu Hou; Chunsik Lee; Yang Li; Arvydas Maminishkis; Zhongshu Tang; Fan Zhang; Harald F Langer; Pachiappan Arjunan; Lijin Dong; Zhijian Wu; Linda Y Zhu; Lianchun Wang; Wang Min; Peter Colosi; Triantafyllos Chavakis; Xuri Li
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

5.  Platelet derived growth factor receptor-beta (PDGFRβ) expression is limited to activated stromal cells in the bone marrow and shows a strong correlation with the grade of myelofibrosis.

Authors:  Judit Bedekovics; Attila Kiss; Lívia Beke; Katalin Károlyi; Gábor Méhes
Journal:  Virchows Arch       Date:  2013-06-08       Impact factor: 4.064

6.  Platelet-derived growth factor-BB controls epithelial tumor phenotype by differential growth factor regulation in stromal cells.

Authors:  Wiltrud Lederle; Hans-Jürgen Stark; Mihaela Skobe; Norbert E Fusenig; Margareta M Mueller
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

7.  Glucose lowers the threshold for human aortic vascular smooth muscle cell migration: inhibition by protein phosphatase-2A.

Authors:  M Campbell; P Anderson; E R Trimble
Journal:  Diabetologia       Date:  2008-03-14       Impact factor: 10.122

Review 8.  Surfing the big WAVE: Insights into the role of WAVE3 as a driving force in cancer progression and metastasis.

Authors:  Khalid Sossey-Alaoui
Journal:  Semin Cell Dev Biol       Date:  2012-10-29       Impact factor: 7.727

9.  Establishment of atypical-teratoid/rhabdoid tumor (AT/RT) cell cultures from disseminated CSF cells: a model to elucidate biology and potential targeted therapeutics.

Authors:  Aru Narendran; Lucas Coppes; Aarthi Jayanthan; Michael Coppes; Bijan Teja; Delphine Bernoux; David George; Douglas Strother
Journal:  J Neurooncol       Date:  2008-07-24       Impact factor: 4.130

10.  Vaccines targeting the neovasculature of tumors.

Authors:  Agata Matejuk; Qixin Leng; Szu-Ting Chou; Archibald J Mixson
Journal:  Vasc Cell       Date:  2011-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.